moringa glp 1 reviews BetterAlt - Nourish 18000mg - 120 Capsules (60 Servings) Advanced GLP-1 Moringa Liquid Support

The neuronal dysfunction that characterizes diabetes,16 hyperglycemia, and dietary modifications that include the use of sweeteners, as well as a greater predisposition to certain psychologic disorders,16 are some of the factors that can independently contribute to or interact together for the development and progression of gastrointestinal symptoms in this group of patients with psychologic disorders.16,17 Diabetic gastrointestinal neuropathy Diabetic gastrointestinal neuropathy can affect any part of the gastrointestinal tract, manifesting as gastroparesis, constipation, or fecal incontinence secondary to visceral neuropathy.16,18 Chronic hyperglycemia conditions an altered enteric microenvironment, with increased oxidative stress, the formation of advanced glycosylation end products, inflammation, and reduced neurotransmitters and local hormones, affecting the enteric vasculature and smooth muscle cellularity.19 Previously described changes affect the sensory, motor, and secretory functions of the digestive tract, contributing to the wide range of gastrointestinal alterations mentioned.18 Gastroparesis is one of the most widely studied gastrointestinal manifestations of diabetic gastrointestinal neuropathy

Reduced Appetite & Nutrient Deficiencies Patients eating 40-60% less food overall Micronutrient deficiencies emerging (B12, iron, calcium, vitamin D) Small eating windows require nutrient-dense solutions Standard supplements not optimized for reduced intake capacity Target Customer Profile Demographics Age: 35-55 (75% female, 25% male) Income: $75,000+ household income Education: College-educated Location: Urban/suburban areas with access to med spas and telehealth Psychographics Weight loss journey: Tried diet/exercise, now using GLP-1 as tool Health-conscious: Wants to lose weight "the right way" (preserving muscle) Information-seeking: Actively researching GLP-1 side effects and solutions Financially stable: Already spending $900-1,500/month on medication Quality-focused: Willing to pay premium for targeted solutions Pain Points (Ranked by Severity) 1

Terns Pharmaceuticals (TERN-601) has an oral GLP-1 agonist in Phase 1/2

Their venom is basically their spit